Evaluating for Type-2 Diabetes in the Very Early Postpartum Period
| Status: | Recruiting |
|---|---|
| Conditions: | Endocrine, Diabetes, Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/8/2019 |
| Start Date: | February 2013 |
| End Date: | July 2020 |
| Contact: | Jolene Muscat, M.D. |
| Email: | jolene.muscat@nyumc.org |
| Phone: | (516) 663-8661 |
Evaluating for Type-2 Diabetes in the Very Early Post-Partum Period
Pregnancy-associated diabetes, known as gestational diabetes mellitus (GDM), is associated
with an increased lifetime risk of developing diabetes mellitus (DM) or pre-diabetes. Up to
30% of women with GDM will continue have abnormal blood glucose tests 6 or more weeks after
delivery. Early diagnosis and treatment of continued impaired glucose metabolism or DM is
essential because serious health problems can result.
Current guidelines recommend a 75-gram, 2-hour glucose tolerance test (GTT) 6 or more weeks
after delivery for women diagnosed with GDM in order to identify those with continued DM or
impaired glucose metabolism. However, approximately half of these women do not get glucose
testing after delivery. The ability to test women while they are still hospitalized after
having a baby could greatly increase diagnosis, care and treatment of women with abnormal
glucose metabolism.
Our objective is to determine if a 75-gram, 2-hour GTT administered to women with GDM two to
four days after delivery can identify those who will have an abnormal GTT at 6-12 weeks after
delivery.
with an increased lifetime risk of developing diabetes mellitus (DM) or pre-diabetes. Up to
30% of women with GDM will continue have abnormal blood glucose tests 6 or more weeks after
delivery. Early diagnosis and treatment of continued impaired glucose metabolism or DM is
essential because serious health problems can result.
Current guidelines recommend a 75-gram, 2-hour glucose tolerance test (GTT) 6 or more weeks
after delivery for women diagnosed with GDM in order to identify those with continued DM or
impaired glucose metabolism. However, approximately half of these women do not get glucose
testing after delivery. The ability to test women while they are still hospitalized after
having a baby could greatly increase diagnosis, care and treatment of women with abnormal
glucose metabolism.
Our objective is to determine if a 75-gram, 2-hour GTT administered to women with GDM two to
four days after delivery can identify those who will have an abnormal GTT at 6-12 weeks after
delivery.
This will be a prospective cohort study conducted at Winthrop-University Hospital. Women 18
years old or older who delivered a child or fetus within the previous 4 days at either
hospital who also were diagnosed with GDM during the pregnancy will be eligible for
participation. Women will be excluded if they have issues that would interfere with
administration of a GTT, are unable /unwilling to provide informed consent, or cannot follow
up. Anticipated enrollment will be 250 women at each study site.
While still hospitalized two to four days postpartum, subjects will undergo a 75-gram, 2-hour
GTT and have blood tested for hemoglobin A1c and glucose levels. They will be reminded to do
the recommended GTT 6-12 weeks after delivery. Maternal, neonatal, and obstetric
characteristics will be collected, including the any GTT results. The results of the
in-hospital GTT will be compared to the result of the GTT taken 6-12 weeks postpartum and
tested for correlation.
years old or older who delivered a child or fetus within the previous 4 days at either
hospital who also were diagnosed with GDM during the pregnancy will be eligible for
participation. Women will be excluded if they have issues that would interfere with
administration of a GTT, are unable /unwilling to provide informed consent, or cannot follow
up. Anticipated enrollment will be 250 women at each study site.
While still hospitalized two to four days postpartum, subjects will undergo a 75-gram, 2-hour
GTT and have blood tested for hemoglobin A1c and glucose levels. They will be reminded to do
the recommended GTT 6-12 weeks after delivery. Maternal, neonatal, and obstetric
characteristics will be collected, including the any GTT results. The results of the
in-hospital GTT will be compared to the result of the GTT taken 6-12 weeks postpartum and
tested for correlation.
Inclusion Criteria:
- Women 18 years old or older
- Delivered a child or fetus within the previous 4 days
- Diagnosed with gestational diabetes during the pregnancy
Exclusion Criteria:
- Unable or unwilling to provide informed consent for the study
- Unable to undergo or complete a 2-hour oral glucose tolerance test 2-4 days postpartum
- Unable or unwilling to have study follow up.
We found this trial at
1
site
259 1st Street
Mineola, New York 11501
Mineola, New York 11501
Principal Investigator: Jolene Muscat, M.D.
Click here to add this to my saved trials
